Announcement of TTY Material Information in May 2020

2020.6.11

Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO 1 Date of announcement 2020/06/11 Time of announcement 14:48:09
Subject Announcement of TTY Biopharm's unaudited income information in May 2020
Date of events 2020/06/11 To which item it meets paragraph 53
Statement 1.Date of occurrence of the event:2020/06/11
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $267,055 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $49,307 thousands, and a consolidated income before tax of $69,731 thousands in May 2020; net income attributed to stockholders of the company was $60,990 thousands; EPS is $0.25.
Year-to-date consolidated net sales was $1,716,528 thousands (in NT dollars; unaudited), a consolidated operating profit was $432,201 thousands and consolidated income before tax was $492,435 thousands until May 2020; year-to-date net income attributed to stockholders of the company was $391,733 thousands; EPS is $1.58.
6.Countermeasures:N/A
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.
TOP